The Indian Pharmaceutical Alliance (IPA) has announced a new leadership team, with Sharvil Patel, Managing Director of Zydus Lifesciences, taking over as President. Patel succeeds Samir Mehta, Chairman of the Torrent Group, and will be joined by Glenn Saldanha, Chairman and Managing Director of Glenmark, who has been appointed as Vice President. This leadership transition comes at a critical time for the Indian pharmaceutical industry, which is poised for growth with recent GST reforms aimed at making healthcare more affordable.
The new leadership team is committed to building on the foundation laid by the IPA, with a focus on innovation, patient access, and quality in healthcare. Patel highlighted the breakthroughs achieved by Zydus Lifesciences, including the development of India’s first new chemical entity (NCE), foray into MedTech, and global CDMO business, as well as advances in vaccines and biologics. He expressed his vision to build a strong, self-reliant India that can deliver high-quality, affordable healthcare solutions.
Saldanha emphasized the importance of innovation in the Indian pharmaceutical industry, citing Glenmark’s recent global partnership with AbbVie as an example of how Indian pharma companies are moving up the innovation curve. He stressed the need for the industry to work together to strengthen India’s leadership in delivering high-quality, affordable, and future-ready healthcare solutions.
Sudarshan Jain, Secretary General of the IPA, noted that the Indian pharmaceutical industry has been playing a vital role in advancing patient care and access. He expressed confidence that the new leadership team will continue to build on recent reforms and breakthroughs, with a focus on innovation, patient access, and quality in healthcare.
As a reliable and trusted news source, it is clear that the Indian pharmaceutical industry is at an inflection point, with significant opportunities for growth and innovation. With the new leadership team at the helm, the IPA is well-positioned to drive the industry forward and achieve its vision of delivering high-quality, affordable healthcare solutions to patients in India and around the world. The IPA’s commitment to innovation, patient access, and quality in healthcare is expected to have a positive impact on the industry and the country as a whole.